Bio engineered stent market
Bio-engineered Stent Market, by Application Type (Coronary Artery Disease, Peripheral Arterial Disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Others), by Product Type (Drug-eluting Stents, Bioabsorbable Stents, and Drug-eluting Balloons), by Mode of Delivery (Balloon-expandable Stents and Self-expanding Stents), by Material Type (Metal-based and Polymer-based), by End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights and Forecast to 2026
- Feb 2019
- CMI2484
- 176 Pages
- Excel & Pdf
- Medical Devices
Global Bio-engineered Stent Market – Life Saving Treatment for Cardiovascular Diseases
Bio-engineered stent plays a major role in modern healthcare as it expands the blood vessel to prevent a blockage of arteries in cardiovascular diseases such as coronary heart disease and ischemic heart disease.
The global bio-engineered stent market size was valued at US$ 2,764.2 million in 2017, and is projected to exhibit a CAGR of 8.7% over the forecast period (2018 – 2026).
Figure 1. Global Bio-engineered Stent Market Value (US$ Mn), by Region, 2017
Source: Coherent Market Insights Analysis (2019)
Increasing prevalence of cardiovascular diseases such as coronary heart disease and ischemic heart disease is expected to propel growth of the bio-engineered stent market
Bio-engineered stent is used in treating blockage of coronary and peripheral artery, which is related to coronary heart disease, ischemic heart disease, and other cardiovascular diseases. High prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to propel demand for bio-engineered stent, which in turn is expected to drive the market growth. According to American Heart Association, in 2018, around 92.1 million people in the U.S. were suffering with some form of cardiovascular diseases or the after-effects of stroke. Moreover, around 836,546 deaths in the U.S. were due to cardiovascular diseases, which accounted for 1 in every 3 deaths in the country. Direct and indirect costs in the treatment of cardiovascular diseases and stroke in the country were estimated to be around US$ 329.7 Million in 2018, which includes both health expenditures and lost productivity.
Similarly, according to World Health Organization (WHO), 2015, cardiovascular diseases are the highest cause of morbidity and mortality worldwide, with around 17.7 million cases representing 31% of all worldwide deaths in 2015, of which around 6.7 million were due to stroke and 7.4 million were due to coronary heart disease.
However, availability of alternatives for the treatment of cardiac diseases, product recalls and failure, and stringent regulations for product approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, a absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.
Figure 2. Global Bio-engineered Stent Market Share (%), by Material, 2018 and 2026
Source: Coherent Market Insights Analysis (2019)
Increasing adoption of bio-engineered stents in North America is expected to bolster the market growth
North America holds a dominant position in the global bio-engineered stent market, owing to rapid growth in geriatric population, increasing incidences of cardiac ailments, coronary and peripheral artery diseases, and high prevalence of obesity in the region. According to World Population Prospects, the number of people aged 80 or over is projected to triple by 2050, from 137 million in 2017 to 425 million in 2050 in the U.S. This age bracket is expected to more than double worldwide, increasing from 962 million in 2017 to 2.1 billion in 2050.
Moreover, key players in the market are focused on receiving regulatory approvals for novel products to reduce the burden of blood stream infections associated with bio-engineered stents. For instance, in September 2018, Biotronik SE & Co. KG received the U.S. Food and Drug Administration (FDA) approval for PK Papyrus covered coronary stent system for the treatment of acute coronary artery.
Key Players
Major players operating in the global bio-engineered stent market include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and JOTEC GmbH.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Application Type
- Market Snippet, By Product Type
- Market Snippet, By Material Type
- Market Snippet, By Mode of Delivery
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Impact Analysis
- Key Highlights
- PEST Analysis
- PORTER’s Analysis
- Mergers and Acquisitions
- Epidemiology
- Global Bio-engineered Stent Market, By Application Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2019– 2026
- Segment Trends
- Coronary artery disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- peripheral arterial disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Carotid Artery Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Renal Artery Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Abdominal Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Thoracic Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Global Bio-engineered Stent Market, By Product Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2019– 2026
- Segment Trends
- Drug-eluting Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Bioabsorbable Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Drug-eluting balloons
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Global Bio-engineered Stent Market, By Mode of Delivery, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2019– 2026
- Segment Trends
- Balloon-expandable Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Self-expanding Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Global Bio-engineered Stent Market, By Material Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2019– 2026
- Segment Trends
- Metal-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Polymer-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Global Bio-engineered Stent Market, By End User, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2019– 2026
- Segment Trends
- Hospitals & Cardiac Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
- Global Bio-engineered Stent Market, By Region, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Application Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Material Type, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Medtronic, plc.*
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boston Scientific Corporation
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott Laboratories
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BIOTRONIK SE & Co. KG
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- B. Braun Melsungen AG
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Terumo Corporation
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- MicroPort Scientific Corporation
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- STENTYS SA
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Meril Life Sciences Pvt. Ltd.
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vascular Concepts
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- W. L. Gore and Associates
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- C. R. Bard
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Endologix, Inc.
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lombard Medical Technologies
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Translumina GmbH
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- JOTEC GmbH
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
*Browse 25 market data tables and 29 figures on "Bio-engineered Stent Market - Global forecast to 2026".